-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transplantation in CML in the TKI Era: Who, When, How?

Program: Education Program
Session: Beyond Routine Frontline Therapy of CML
Sunday, December 11, 2022, 4:30 PM-5:45 PM

Nicolaus Kroeger, MD

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Disclosures: Kroeger: Kite/Gilead: Honoraria; Novartis: Honoraria, Research Funding; Neovii: Honoraria, Research Funding; Sanofi: Honoraria; JAZZ: Honoraria; BMS: Honoraria, Research Funding; Riemser: Honoraria, Research Funding; Amgen: Honoraria; MIltenyi: Honoraria; Therakos: Honoraria.

See more of: Beyond Routine Frontline Therapy of CML
See more of: Education Program
<< Previous Presentation | Next Presentation >>